An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT01684865 · COMPLETED
Trial details
- NCT number
- NCT01684865
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-10-22
- Primary completion
- 2017-11-27
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.